BioXcel Therapeutics (BTAI) CEO On Using A.I. To Discover New Drug Candidates

BioXcel Therapeutics (BTAI) is a commercial-stage biopharmaceutical company that utilizes A.I. to develop medicines in neuroscience and immuno-oncology. CEO Vimal Mehta joins Nicole Petallides to give an overview of BTAI. He discusses using A.I. to discover new drug candidates. He also talks about how BTAI is expecting data in treatments for Alzheimer's and Schizophrenia. He notes that the company is also using A.I. to move into the Alzheimer's education space. Tune in to find out more about the stock market today.